A new edition of the Handbook has always seen important developments, and this edition is no exception. Not only has the entire volume been reviewed and updated, significant new content has been added.
Special offer price - available now.
A new edition of the Handbook has always seen important developments, and this edition is no exception. Not only has the entire volume been reviewed and updated, significant new content has been added.
This includes 40 new monographs – bringing the total to 380 – written by a team of over 150 of the world’s leading pharmaceutical scientists. Monographs are extensively illustrated with images(SEMs), chemical structures, spectra and tables to support easy interpretation of the text.
With every new edition, the Handbook has increased in breadth and depth, making it increasingly valuable to drug formulators, manufacturers, regulatory and legal bodies, and establishing it as the go-to reference work on excipients. Pharmacists and chemists – in practice, in training and at work in a wide variety of industries – rely upon its authority and trust its content.
No reference work surpasses the Handbook of Pharmaceutical Excipients in the international recognition of the authority of its content and the respect for its editorial board and contributors.
“…the publisher and editors have once again published an excellent book which has utility for all of us involved in the pharmaceutical industry.” .
The British Toxicology Society
Clinical Supply Planning in Europe - Balancing Cost, Flexibility and Time
December 19th 2024The packaging and distribution of clinical supplies is a fundamental piece to the overall success of a clinical trial, and advance preparation can help establish a more efficient supply chain. Selecting the best geographical location for those activities, however, depends on the clinical trial protocol, business decisions, and even the investigational medicinal product (IMP) being studied.